In MS, microglia and oligodendrocytes promote inflammatory demyelination through GSDMD-mediated pyroptosis. Inhibiting pyroptosis can improve neuronal damage and alleviate disease progression. The gene discussed is GSDMD; the disease is myeloid sarcoma.